Health and Care says blood stocks remain good but new donors are "always welcome". An organisation says those with health conditions should avoid second-hand vapour "like the plague". Regan Sparks, who has cystic fibrosis, takes medication that means she is…
Naval Health Clinic New England (NHCNE) was formally recognized for its significant contributions to the Department of Defense Global Respiratory Surveillance Program (DoDGRSP) during the 2025–26 respiratory season. Naval Health Clinic New England Recognized for Support to DoD Global Respiratory Surveillance…
From taladegib to admilparant and inhaled treprostinil, here are the key 2026 advances in idiopathic pulmonary fibrosis care. Researchers and pharmaceutical companies made major strides in idiopathic pulmonary fibrosis (IPF) care this year with a host of investigational clinical trials, new…
WEST Yorkshire is among the highest spenders on NHS prescriptions. A new study by Cured Pharmacy found that the West Yorkshire Integrated Care Board (ICB) spends £292.42 per person on prescriptions, the third-highest rate in England. The area recorded the largest…
Asthma is a chronic lung condition that affects around 339.4 million people worldwide.1 Asthma can be debilitating in everyday life when uncontrolled, with approximately 39% of people living with asthma remaining uncontrolled despite current medicine and the availability of effective treatment options.
Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, presented a poster at the CHEST 2026 Annual Meeting in Phoenix, Arizona. The... -- Post-Hoc Analysis of the Phase 2/3 IMPALA Clinical Trial Presented in a Poster…
Aptar Pharma, a global leader in drug delivery, dosing, protection technologies and services, today announced a collaboration with Aceso Therapeutics, a biotech developing novel therapies for cystic fibrosis (CF), a rare genetic disease, to advance the development of ACT-101, an…
Aizawl, Oct 29 (PTI) Respiratory diseases accounted for the largest proportion of medically certified deaths in Mizoram in 2025, followed by digestive ailments, according to a report released by the northeastern state’s chief registrar of births and deaths. The Medical Certification of…
A new medication has been added to the treatment options for children with moderate-to-severe asthma. In a late-stage clinical trial, the biologic agent dupilumab reduced the rate of severe asthma attacks and improved lung function and asthma control for children…
TARRYTOWN, N.Y. and PARIS, March 4, 2021 /PRNewswire/ -- Submission supported by data demonstrating Dupixent significantly reduced severe asthma attacks and is the only biologic to improve lung function in children aged 6 to 11 years in a randomized Phase 3 trial Dupixent has the potential to…
Asthma, COPD, pulmonary fibrosis, cystic fibrosis and other lung diseases: new treatments, research and living with a chronic lung condition.
An article joins this feed when it matches these terms. Each one is also a search of its own.